Postoperative early ultrasensitive prostate-specific antigen identifies patients at risk for biochemical recurrence in margin positive prostate cancers: a single-center study

@article{Hatano2017PostoperativeEU,
  title={Postoperative early ultrasensitive prostate-specific antigen identifies patients at risk for biochemical recurrence in margin positive prostate cancers: a single-center study},
  author={Koji Hatano and Takuya Okusa and Yu Ishizuya and Yasutomo Nakai and Masashi Nakayama and Ken-ichi Kakimoto and Kazuo Nishimura},
  journal={Japanese Journal of Clinical Oncology},
  year={2017},
  volume={47},
  pages={74–79}
}
Objective To identify predictors for biochemical recurrence among patients with positive surgical margins (RM1) after radical prostatectomy and to examine the effect of ultrasensitive prostate-specific antigen measured early after prostatectomy on biochemical recurrence. Methods We identified 705 patients with prostate cancer who were treated with radical prostatectomy without preoperative hormonal therapy at our institution between 2000 and 2014. The patients with RM1 who had a postoperative… 

Figures and Tables from this paper

68Ga-HBEDD PSMA-11 PET/CT staging prior to radical prostatectomy in prostate cancer patients: Diagnostic and predictive value for the biochemical response to surgery.

TLDR
This is one of the first studies to correlate the PSMA PET's staging capacity to prostate cancer patient's outcomes to radical prostatectomy and indicates it's potential in predicting which patients will benefit from radical prostateCTomy.

External validation of two web-based postoperative nomograms predicting the probability of early biochemical recurrence after radical prostatectomy: a retrospective cohort study

The present study aimed to validate and compare the predictive accuracies of the Memorial Sloan Kettering Cancer Center (MSKCC) and Johns Hopkins University (JHU) web-based postoperative nomograms

References

SHOWING 1-10 OF 34 REFERENCES

Usefulness of postoperative nadir prostate-specific antigen value by ultrasensitive assay as a predictor of prostate-specific antigen relapse for pathological T3 or positive surgical margins after radical prostatectomy for prostate cancer

TLDR
Postoperative nadir PSA value obtained by ultrasensitive assay was useful as a predictor of PSA relapse among patients with adverse pathological features in prostate cancer patients with pathological T3 or positive surgical margins.

The use of early postoperative prostate-specific antigen to stratify risk in patients with positive surgical margins after radical prostatectomy

TLDR
The level of ultrasensitive PSA yields valuable information about the prostatectomy outcome already at the first month after the surgery and should aid risk stratification in patients with PSM and may spared the toxicity of immediate adjuvant radiotherapy.

Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality.

Prostate-specific antigen measured 3 months after radical prostatectomy as a new predictor of biochemical recurrence

TLDR
3M-PSA is an independent predictor of BCR-free survival and might be used for a risk-adjusted follow-up protocol.

The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence

TLDR
This study provides data on the BCR in pT2R1-PCa without adjuvant/neoadjuvant therapy and thus a rationale for an individual’s risk stratification and thus serve to personalize the management in p T2R 1- PCa.

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.

TLDR
Nearly half of patients with recurrent prostate cancer after radical prostatectomy have a long-term PSA response to SRT when treatment is administered at the earliest sign of recurrence, which should prove valuable for medical decision making for patients with a rising PSA level.